Cubist Systematic Strategies, LLC United Therapeutics Corp Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$210.76 - $249.51 $11.3 Million - $13.4 Million	-53,727 Reduced 98.38%	886 $203,000
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $3.91 Million - $4.68 Million	18,209 Added 50.02%	54,613 $12 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $7.71 Million - $9.04 Million	36,404 New	36,404 $8.22 Million
Q1 2023 May 15, 2023	SELL	$212.99 - $276.17 $10.4 Million - $13.5 Million	-49,061 Reduced 88.26%	6,529 $1.46 Million
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $10.7 Million - $14.6 Million	51,970 Added 1435.64%	55,590 $15.5 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $7.76 Million - $9.32 Million	-38,162 Reduced 91.34%	3,620 $758,000
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $6.68 Million - $9.22 Million	38,225 Added 1074.64%	41,782 $9.85 Million
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $1.55 Million - $2 Million	-9,346 Reduced 72.43%	3,557 $638,000
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $5.87 Million - $6.88 Million	-31,833 Reduced 71.16%	12,903 $2.79 Million
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $7.93 Million - $9.47 Million	44,091 Added 6835.81%	44,736 $8.26 Million
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $1.07 Million - $1.32 Million	-6,248 Reduced 90.64%	645 $116,000
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $357,602 - $406,176	2,323 Added 50.83%	6,893 $1.15 Million
Q4 2020 Feb 16, 2021	SELL	$101.87 - $151.79 $4.53 Million - $6.75 Million	-44,455 Reduced 90.68%	4,570 $694,000
Q3 2020 Nov 16, 2020	BUY	$99.9 - $121.13 $3.24 Million - $3.93 Million	32,414 Added 195.14%	49,025 $4.95 Million
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $2.15 Million - $2.92 Million	-23,220 Reduced 58.3%	16,611 $2.01 Million
Q1 2020 May 15, 2020	SELL	$79.39 - $115.35 $4.03 Million - $5.85 Million	-50,729 Reduced 56.02%	39,831 $3.78 Million
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $278,861 - $339,505	-3,561 Reduced 3.78%	90,560 $7.98 Million
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $2.56 Million - $2.95 Million	34,250 Added 57.21%	94,121 $7.51 Million
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $3.95 Million - $6.28 Million	51,990 Added 659.69%	59,871 $4.67 Million
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $736,656 - $872,025	6,875 Added 683.4%	7,881 $925,000
Q4 2018 Feb 14, 2019	BUY	$101.4 - $128.73 $102,008 - $129,502	1,006 New	1,006 $110,000
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $555,620 - $632,023	-4,882 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $493,765 - $577,589	4,882 New	4,882 $552,000
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $275,958 - $391,093	-2,574 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $353,368 - $450,814	-2,980 Reduced 53.66%	2,574 $381,000
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $636,488 - $759,842	5,554	5,554 $651,000

Others Institutions Holding UTHR

# of Institutions

679

Shares Held

42.1M

Call Options Held

194K

Put Options Held

295K

Black Rock Inc. New York, NY

5.47M
Shares

$2.03 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.41M
Shares

$1.64 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.17M
Shares

$1.18 Billion
0.2% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1.06 Billion
15.42% of portfolio
State Street Corp Boston, MA

2.24M
Shares

$830 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account